cytarabine has been researched along with Plasma Cell Tumor in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (70.59) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Barlogie, B; Mouhieddine, TH; Teruya-Feldstein, J | 1 |
| Cavenagh, J; Ingram, W; Quinn, J; Smith, D; Stevens, J; Yong, K | 1 |
| Jin, J; Liu, H; Tong, HY; Wei, JY; Yu, WJ; Zhang, FJ; Zhu, WF | 1 |
| Ciurnelli, R; Colagrande, M; Di Ianni, M; Gallucci, M; Mariani, G; Tabilio, A | 1 |
| Arita, N; Kajiwara, S; Kono, H; Ohmori, T; Tabei, R | 1 |
| Chiu, IM; Marzluff, WF | 1 |
| Au, WY; Choy, C; Kwong, YL | 1 |
| Igarashi, T; Kishimoto, T; Okada, M; Yamamura, Y | 1 |
| Bergsagel, DE; Librach, SL; Ogawa, M | 1 |
| Bichel, P; Dombernowsky, P | 1 |
| Kemper, B; Rich, A | 1 |
| Albrecht, M; Fülle, HH | 1 |
| Dominick, CA; Dykes, DJ; Griswold, DP; Kelley, CA; Roberts, BJ | 1 |
| Adamson, RH; Hahn, MA | 1 |
| Mattern, J; Volm, M; Wayss, K | 1 |
| Cohen, SL; Dodsworth, H; Whitelaw, AG | 1 |
| Griswold, DP; Schabel, FM; Simpson-Herren, L | 1 |
17 other study(ies) available for cytarabine and Plasma Cell Tumor
| Article | Year |
|---|---|
Hemophagocytic relapsed intramedullary plasmacytoma.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Bortezomib; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Magnetic Resonance Imaging; Melphalan; Neoplasm Recurrence, Local; Oligopeptides; Plasmacytoma; Positron Emission Tomography Computed Tomography; Pubic Bone; Rare Diseases; Stem Cell Transplantation; Thalidomide; Transplantation, Autologous; Treatment Outcome | 2020 |
Myeloma presenting during pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cesarean Section; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypercalcemia; Idarubicin; Infant, Newborn; Lenalidomide; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Myeloma Proteins; Osteolysis; Plasmacytoma; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrazines; Remission Induction; Spinal Cord Compression; Thalidomide; Thoracic Vertebrae; Transplantation, Autologous | 2014 |
Bortezomib in treatment of extramedullary plasmacytoma of the pancreas.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Middle Aged; Pancreatic Neoplasms; Plasmacytoma; Pyrazines; Retreatment; Treatment Outcome; Vincristine | 2009 |
Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis.
Topics: Antimetabolites, Antineoplastic; Cytarabine; Female; Humans; Injections, Spinal; Meninges; Middle Aged; Orbital Neoplasms; Plasmacytoma | 2007 |
Primary colonic plasmacytoma associated with acute myelogenous leukemia.
Topics: Adult; Colon; Colonic Neoplasms; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Plasmacytoma; Prednisolone | 1984 |
Uncoordinate synthesis of histone H1 in cells arrested in the G1 phase.
Topics: Animals; Cell Cycle; Cell Line; Culture Media; Cytarabine; DNA Replication; Histones; Hydroxyurea; Interphase; Mice; Plasmacytoma; Protein Biosynthesis; RNA, Messenger | 1982 |
Plasma cell leukemia evolving into aggressive extramedullary plasmacytoma by clonal selection.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clone Cells; Cytarabine; Dexamethasone; Humans; Immunoglobulin Class Switching; Leukemia, Plasma Cell; Male; Middle Aged; Pelvic Neoplasms; Plasmacytoma; Tomography, X-Ray Computed; Vincristine | 1997 |
In vitro induction of polyclonal killer T cells with 2-mercaptoethanol and the essential role of macrophages in this process.
Topics: Animals; Antigens, Neoplasm; Burkitt Lymphoma; Cell Division; Cells, Cultured; Clone Cells; Cytarabine; Cytotoxicity Tests, Immunologic; DNA; Epitopes; Female; Hydroxyurea; Immunity, Cellular; In Vitro Techniques; Leukemia, Experimental; Macrophages; Mast-Cell Sarcoma; Mercaptoethanol; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Plasmacytoma; T-Lymphocytes | 1977 |
Mouse myeloma. A model for studies of cell kinetics.
Topics: Alkylating Agents; Animals; Bone Marrow; Bone Marrow Cells; Bone Neoplasms; Cell Division; Cells, Cultured; Cyclophosphamide; Cytarabine; Disease Models, Animal; Kinetics; Melphalan; Methotrexate; Mice; Mice, Inbred BALB C; Myeloma Proteins; Neoplasms, Experimental; Plasmacytoma; Thymidine; Tritium; Vinblastine; Vincristine | 1975 |
Recycling of resting cells in the JB-1 ascites tumour after treatment with 1-beta-D-arabinofuranosylcytosine (ara-C).
Topics: Animals; Autoradiography; Cell Division; Cytarabine; DNA, Neoplasm; Male; Mice; Mice, Inbred Strains; Mitotic Index; Neoplasms, Experimental; Plasmacytoma; Spectrophotometry; Thymidine | 1976 |
Identification of presumptive histone messenger RNA in rapidly labelled polysomal RNA of mouse myelomas.
Topics: Animals; Centrifugation, Density Gradient; Cytarabine; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Female; Histones; Isotope Labeling; Mice; Mice, Inbred BALB C; Multiple Myeloma; Neoplasms, Experimental; Plasmacytoma; Polyribosomes; RNA, Messenger; RNA, Ribosomal; Spectrophotometry, Ultraviolet; Time Factors; Tritium; Uridine | 1973 |
[Morphology of megakaryocytes in hematologic diseases].
Topics: Anemia, Pernicious; Blood Cell Count; Bone Marrow Cells; Cytarabine; Cytoplasm; Follow-Up Studies; Hematologic Diseases; Humans; In Vitro Techniques; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Megakaryocytes; Mercaptopurine; Plasmacytoma; Polycythemia; Thioguanine; Thrombocytopenia | 1974 |
Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
Topics: Adenocarcinoma; Amides; Androstanols; Animals; Antineoplastic Agents; Cricetinae; Cyclohexanes; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Estradiol; Female; Hydroxyurea; Imidazoles; Mammary Neoplasms, Experimental; Melanoma; Melphalan; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Plasmacytoma; Progesterone; Rats; Sarcoma, Experimental; Triazenes | 1974 |
Pharmacology of 3,5-diamino-1,24-triazole (guanazole). 1. Antitumor activity of guanazole.
Topics: Amines; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cyclophosphamide; Cytarabine; Depression, Chemical; Female; Hydroxyurea; In Vitro Techniques; Leukemia L1210; Leukemia, Experimental; Lymphoma, Large B-Cell, Diffuse; Male; Mast-Cell Sarcoma; Methotrexate; Mice; Neoplasms, Experimental; Nitrosourea Compounds; Plasmacytoma; Structure-Activity Relationship; Triazoles | 1972 |
The effects of cytostatic drugs on transplanted tumours. An investigation of the correlation between in vivo and in vitro results.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cricetinae; Cytarabine; Daunorubicin; Fluorouracil; Melanoma; Methotrexate; Mice; Neoplasm Transplantation; Plasmacytoma; Procarbazine; Rats; Thymidine; Tritium; Uridine | 1974 |
Leukaemia on myeloma.
Topics: Adult; Bronchopneumonia; Cytarabine; Humans; Leukemia, Myeloid, Acute; Male; Melphalan; Multiple Myeloma; Plasmacytoma; Thioguanine | 1971 |
Altered sensitivity of a hamster plasmacytoma to cytosine arabinoside (NSC-63878).
Topics: Animals; Antineoplastic Agents; Cell Survival; Cricetinae; Cyclophosphamide; Cytarabine; Neoplasm Transplantation; Neoplasms, Experimental; Plasmacytoma; Thymidine; Time Factors | 1970 |